Literature DB >> 3106448

Chrysotherapy in the treatment of corticosteroid-dependent asthma.

W B Klaustermeyer, D T Noritake, F K Kwong.   

Abstract

The efficacy of parenteral gold therapy was evaluated in patients with steroid-dependent asthma. Five of eight patients improved in terms of reduced steroid requirement while they were maintaining or improving lung function. Two patients developed significant proteinuria that resolved with cessation of gold. Chrysotherapy appears to have a corticosteroid-sparing effect in some patients and may have a useful role in the management of severe refractory asthma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106448     DOI: 10.1016/0091-6749(87)90202-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

Review 1.  Corticosteroid sparing agents in asthma.

Authors:  J M Hill; A E Tattersfield
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

2.  Treatment of chronic severe asthma.

Authors:  H A Boushey
Journal:  West J Med       Date:  1997-11

Review 3.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

4.  Intramuscular high-dose triamcinolone acetonide in the treatment of severe chronic asthma.

Authors:  L Mancinelli; L Navarro; O P Sharma
Journal:  West J Med       Date:  1997-11

Review 5.  Corticosteroid-induced bone loss. Prevention and management.

Authors:  C Picado; M Luengo
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

6.  Auranofin in the treatment of steroid dependent asthma: a double blind study.

Authors:  G Nierop; W P Gijzel; E H Bel; A H Zwinderman; J H Dijkman
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 7.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 8.  Outpatient treatment of adult asthma.

Authors:  E C Kleerup; D P Tashkin
Journal:  West J Med       Date:  1995-07

9.  Clinical and molecular aspects of glucocorticoid resistant asthma.

Authors:  Chris J Corrigan; Tuck-Kay Loke
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.